Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection

Phase 2 Completed 70 enrolled Baxter Healthcare Corporation Baxter Innovations GmbH · collab

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the study is to compare safety and efficacy of Fibrin Sealant (FS) Vapor Heated (VH) S/D 500 s-apr with manual compression as a supportive treatment of local bleeding (i.e. oozing) in hepatic resection surgery when standard surgical techniques are insufficient.

Timeline

Start: 2010-11
Primary completion: 2011-07
Completion: 2011-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fibrinogen Concentrate Human	Protein / enzyme biologic	—	Other

Indications

No indication recorded.